Portal de Periódicos da CAPES

Augmenter of liver regeneration: Its place in the universe of hepatic growth factors

1994; Lippincott Williams & Wilkins; Volume: 20; Issue: 3 Linguagem: Inglês

10.1016/0270-9139(94)90113-9

1527-3350

A. Francavilla,

Pancreatic function and diabetes

HepatologyVolume 20, Issue 3 p. 747-757 Special ArticleFree Access Augmenter of liver regeneration: Its place in the universe of hepatic growth factors Antonio Francavilla Ph.D., Corresponding Author Antonio Francavilla Ph.D. The Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213Veterans Administration Medical Center, University Drive C, Building 6, Room 110, Pittsburgh, PA 15240===Search for more papers by this authorMichio Hagiya, Michio Hagiya Toyobo Company, Ltd., Ohtsu, 520–22 Shiga, JapanSearch for more papers by this authorKendrick A. Porter, Kendrick A. Porter The Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213Search for more papers by this authorLorenzo Polimeno, Lorenzo Polimeno The Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213Search for more papers by this authorIzumi Ihara, Izumi Ihara Toyobo Company, Ltd., Ohtsu, 520–22 Shiga, JapanSearch for more papers by this authorThomas E. Starzl, Thomas E. Starzl the Department of Gastroenterology, University of Bari, 70100 Bari, Italy the Department of Experimental Pathology, St. Mary's Hospital and Medical School, London WC1 B3SL, W2, United KingdomSearch for more papers by this author Antonio Francavilla Ph.D., Corresponding Author Antonio Francavilla Ph.D. The Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213Veterans Administration Medical Center, University Drive C, Building 6, Room 110, Pittsburgh, PA 15240===Search for more papers by this authorMichio Hagiya, Michio Hagiya Toyobo Company, Ltd., Ohtsu, 520–22 Shiga, JapanSearch for more papers by this authorKendrick A. Porter, Kendrick A. Porter The Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213Search for more papers by this authorLorenzo Polimeno, Lorenzo Polimeno The Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213Search for more papers by this authorIzumi Ihara, Izumi Ihara Toyobo Company, Ltd., Ohtsu, 520–22 Shiga, JapanSearch for more papers by this authorThomas E. Starzl, Thomas E. Starzl the Department of Gastroenterology, University of Bari, 70100 Bari, Italy the Department of Experimental Pathology, St. Mary's Hospital and Medical School, London WC1 B3SL, W2, United KingdomSearch for more papers by this author First published: September 1994 https://doi.org/10.1002/hep.1840200328Citations: 93AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Meyer WH Jr, Starzl TE. The effect of Eck and reverse Eck fistula in dogs with experimental diabetes mellitus. Surgery 1959; 45: 760–764. 2 Starzl TE, Butz GW Jr, Meyer WH Jr, Torok EE, Dolkar RE. Effect in dogs of various portal vein shunts on response to insulin. Am J Physiol 1962; 203: 275–277. 3 Starzl TE, Scanlan WA, Thornton FH, Wendel RM, Stearn B, Lazarus RE, McAllister W, Shoemaker WC. Effect of insulin on glucose metabolism in the dog after portacaval transposition. Am J Physiol 1965; 209: 221–226. 4 Hahn M, Massen O, Nencki M, Pavlow J. Die Eck'sche Fistel zwischen der unteren Hohlvene und der Pfortader und ihre Folgen fur den Organismus. Arch Exp Path Pharm 1893; 32: 161–210. 5 Bollman JL. The animal with an Eck fistula. Physiol Rev 1961; 41: 607–621. 6 Starzl TE, Kaupp HA Jr, Brock DR, Lazarus RE, Johnson RV. Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow. Surg Gynecol Obstet 1960; 111: 733–743. 7 Starzl TE, Marchioro TL, Rowlands DT Jr, Kirkpatrick CH, Wilson WEC, Rifkind D, Waddell WR. Immunosuppression after experimental and clinical homotransplantation of the liver. Ann Surg 1964; 160: 411–439. 8 Marchioro TL, Porter KA, Dickinson TC, Faris TD, Starzl TE. Physiologic requirements for auxiliary liver homotransplantation. Surg Gynecol Obstet 1965; 121: 17–31. 9 Marchioro TL, Porter KA, Brown BI, Otte J-B, Starzl TE. The effect of partial portacaval transposition on the canine liver. Surgery 1967; 61: 723–732. 10 Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, Putnam CW. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 1973; 137: 179–199. 11 Starzl TE, Porter KA, Putnam CW. Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet 1975; 2: 1241–1246. 12 Starzl TE, Jones AF, Terblanche J, Usui S, Porter KA, Mazzoni G. Growth-stimulating factor in regenerating canine liver. Lancet 1979; 1: 127–130. 13 Francavilla A, Ove P, Wu SK, DiLeo A, Van Thiel D, Starzl TE. Extraction of hepatic stimulatory activity (HSA) from (adult) rat liver following T3 injection (Abstract). Hepatology 1982; 2: 704. 14 Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, Rose J, Van Thiel DH, Starzl TE. Extraction and partial purification of hepatic stimulatory substance in rats, mice and dogs. Cancer Res 1987; 47: 5600–5605. 15 Francavilla A, Barone M, Van Thiel DH, Mazzaferro V, Prelich J, Starzl TE. Further steps of HSS (hepatic stimulatory substance) purification. Dig Dis Sci 1991; 36: 674–680. 16 Francavilla A, Polimeno L, Barone M, Azzarone A, Starzl TE. Hepatic regeneration and growth factors. J Surg Oncol 1993; 3(suppl): 1–7. 17 Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, Shimonishi M, Porter K, Starzl TE. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994; 91: 8142–8146. 18 Francavilla A, Starzl TE, Porter K, Scotti-Foglieni C, Michalopoulos GK, Carrieri G, Trejo J, et al. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck fistula. Hepatology 1991; 14: 665–670. 19 Mazzaferro V, Porter KA, Scotti-Foglieni CL, Venkataramanan R, Makowka L, Rossaro L, Francavilla A, et al. The hepatotrophic influence of cyclosporine. Surgery 1990; 107: 533–539. 20 Starzl TE, Porter KA, Mazzaferro V, Todo S, Fung J, Francavilla A. Hepatotrophic effects of FK 506 in dogs. Transplantation 1991; 51: 67–70. 21 Starzl TE, Schrieber SL, Albers MW, Porter KA, Foglieni CS, Francavilla A. Hepatotrophic properties in dogs of human FKBP, the binding protein for FK 506 and rapamycin. Transplantation 1991; 52: 751–753. 22 Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng QH, Cillo V, Porter K, Starzl TE. The effect on the canine Eck fistula liver of intraportal TGF-Beta alone or with hepatic growth factors. Hepatology 1992; 16: 1267–1270. 23 Francavilla A, Starzl TE, Scotti C, Carrieri C, Azzarone S, Zeng DH, Porter KA, Schreiber S. Inhibition of liver, kidney and intestine regeneration by rapamycin. Transplantation 1992; 53: 496–498. 24 Eck NV. K voprosu o perevyazkie vorotnois veni: Predvaritelnoye soobschjenye. Voen Med J 130: 1–2, 1877. (Translation: Ligature of the portal vein). Child C. G. III: Surg Gynecol Obstet 1953; 96: 375–376. 25 Welch CS. A note on transplantation of the whole liver in dogs. Transplant Bull 1955; 2: 54. 26 Lisowsky T. Dual function of a new nuclear gene for oxidative phosphorylation and vegetative growth in yeast. Mol Gen Genet 1992; 232: 58–64. 27 Morstyn G, Burgess AW. Hemopoietic growth factors: A review. Cancer Res 1988; 48: 5624–5637. 28 Moore MAS. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991; 78: 1–19. 29 Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med Part I 1992; 327: 28–35; N Engl J Med Part Part II 1992; 327: 99–106. 30 Wu GY, Wilson JM, Shalaby F, Grossman M, Shafritz DA, Wu CH. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J Biol Chem 1991; 266: 1438–42. 31 Starzl TE, Lee IY, Porter KA, Putnam CW. The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet 1975; 140: 381–396. 32 Putnam CW, Porter KA, Starzl TE. Hepatic encephalopathy and light electron micrographic changes of the baboon liver after portal diversion. Ann Surg 1976; 184: 155–161. 33 Starzl TE, Porter KA, Francavilla A. The Eck fistula in animals and humans. Curr Probl Surg 1983; 20: 687–752. 34 Starzl TE, Watanabe K, Porter KA, Putnam CW. Effects of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet 1976; 1: 821–825. 35 Rubin E, Gevirtz NR, Cohan P, Tomita F, Jacobson JH. Liver cell damage produced by portacaval shunt. Proc Soc Exp Biol Med 1965; 118: 235. 36 Starzl TE, Porter KA, Kashiwagi N, Putnam CW. Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet 1975; 141: 843–858. 37 Oudea P, Bismuth H. L'Anastomose porto-cave experimentale chez le rat normal. Pathol Biol 1965; 13: 288. 38 Mallet-Guy Y, Hezez G, Feroldi J. Anastomose portocave latero-laterale experimentale. Documents histologiques et electro-microscopiques. Lyon Chir 1972; 68: 436. 39 Starzl TE, Porter KA, Kashiwagi N, Lee IY, Russell WJI, Putnam CW. The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet 1975; 140: 549–562. 40 Gerschenson LE, Okigaki T, Anderson M, Molson J, Davidson MB. Fine structural and growth characteristics of cultured rat liver cells: insulin effects. Exp Cell Res 1972; 71: 49–58. 41 Richman RA, Claus TH, Pikes SJ, Friedman DL. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci U S A 1976; 73: 3589–3592. 42 Bernaert D, Wanson J-C, Drochmans P, Popowski A. Effect of insulin on ultrastructure and glycogenesis in primary cultures of adult rat hepatocytes. J Cell Biol 1977; 74: 878–900. 43 Starzl TE, Francavilla A, Porter KA, Benichou J, Jones AF. The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet 1978; 147: 193–207. 44 Starzl TE, Francavilla A, Porter KA, Benichou J. The effect upon the liver of evisceration with or without hormone replacement. Surg Gynecol Obstet 1978; 146: 524–531. 45 Short J, Brown RF, Husakova A, Gilbertson JR, Zemel R, Lieberman I. Induction of deoxyribonucleic acid synthesis in the liver of the intact animal. J Biol Chem 1972; 247: 1757–66. 46 Leffert H, Alexander NM, Faloona G, Rubalcava B, Unger R. Specific endocrine and hormonal receptor changes associated with liver regeneration in adult rats. Proc Natl Acad Sci U S A 1975; 72: 4033–4036. 47 Holley RW. Control of growth of mammalian cells in cell culture. Nature 1975; 258: 487–490. 48 Bucher NLR, Swaffield MN. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci U S A 1975; 72: 1157–1160. 49 Michalopoulos G, Cianciulli HD, Novotny AR, Kligerman AD, Strom SC, Jirtle RL. Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res 1982; 42: 4673–4682. 50 Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450–1459. 51 Starzl TE, Terblanche J. Hepatotrophic substances. In: H Popper, F Schaffner, eds. Progress in liver diseases, Vol. 6. New York: Grune and Stratton, 1979: 135–152. 52 Higgins GM, Anderson RM. Experimental pathology of liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186–202. 53 McJunkin FA, Breuhaus HC. Homologous liver as a stimulus to hepatic regeneration. AMA Arch Pathol 1931; 12: 900–908. 54 Teir H, Ravanti K. Mitotic activity and growth factors in the liver of the whole rat. Exp Cell Res 1953; 5: 500–507. 55 Blomquist K. Growth stimulation in the liver and tumor development following intraperitoneal injections of liver homogenates in the rat. Acta Pathol Microbiol Scand 1957; 121: 121. 56 LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (HSS) from rat liver. J Physiol 1975; 248: 273–284. 57 Terblanche J, Porter KA, Starzl TE, Moore J, Patzelt L, Hayashida N. Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regeneration dog liver. Surg Gynecol Obstet 1980; 151: 538–544. 58 Francavilla A, Porter KA, Benichou J, Jones AF, Starzl TE. Liver regeneration in dogs: morphologic and chemical changes. J Surg Res 1978; 25: 409–419. 59 Starzl TE, Porter KA, Terblanche J. Inter-organ communications: with particular reference to hepatotrophic factors and intrinsic liver growth factors. In: H Popper, F Gudat, L Bianchi, W Reutter, eds. Communications of Liver Cells Proceedings of Falk-Symposium No. 27. Lancaster, UK: PTP Press Ltd, 1980: 93–97. 60 Francavilla A, DiLeo A, Polimeno L, Gavaler J, Pellicci R, Todo S, Kam I, et al. The effect of hepatic stimulatory substance isolated from regenerating hepatic cytosol and 50,000 and 30,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with d-Galactosamine. Hepatology 1986; 6: 1346–1351. 61 Francavilla A, Ove P, Van Thiel D, Coetzee ML, Wu SK, DiLeo A, Starzl TE. Induction of hepatocyte stimulating activity by T3 and appearance of the activity despite inhibition of DNA synthesis by adriamycin. Horm Metabol Res 1984; 16: 237–242. 62 LaBrecque DR, Steele G, Fogerty S, Wilson M, Barton J. Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 1987; 7: 100–106. 63 LaBrecque DR, Suksang C, Guillaumee D. Purification of hepatic stimulator substance(ss) to homogeneity [Abstract]. Hepatology 1991; 14: 128A. 64 Fleig WE, Hoss G. Partial purification of rat hepatic stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes. Hepatology 1989; 9: 240–248. 65 Matsumoto K, Takehara T, Inoue H, Hagiya M, Shimizu S, Nakamura T. Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities. Biochem Biophys Res Comm 1991; 181: 691–699. 66 Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ. Rat transforming growth factor type I: structure and relation to epidermal growth factor. Science 1984; 223: 1079–1082. 67 Makowka L, Svanas G, Esquivel CO, Venkataramanan R, Todo S, Iwatsuki S, Van Thiel D, Starzl TE. The effect of cyclosporine on hepatic regeneration. Surg Forum 1986; 37: 353–354. 68 Francavilla A, Barone M, Todo S, Zeng Q, Porter KA, Starzl TE. Augmentation of rat liver regeneration by FK 506 compared with cyclosporine. Lancet 1989; 1: 1248–1249. 69 Starzl TE, Fung JJ. Contempo 90: Transplantation. JAMA 1990; 263: 2686–2687. 70 Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK 506. Immunol Today 1992; 13: 136–142. 71 Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991; 251: 283–287. 72 Callebaut I, Renoir JM, Lebeau MC, Massol N, Burny A, Baulieu EE, Mornon JP. An immunophilin that binds Mr 90,000 heat shock protein: Main structural features of a mammalian p59 protein. Proc Natl Acad Sci U S A 1992; 89: 6270–6274. 73 Xu Q, Leiva MC, Fischkoff MK, Handschumacher RE, Lyttle CR. Leukocyte chemotactic activity of cyclophilin. J Biol Chem 1992; 267: 11968–11971. 74 Chung J, Kuo J, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992; 69: 1227–1236. 75 Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK 506 and rapamycin. J Immunol 1990; 144: 251–258. 76 Bierer BE, Mattila PS, Standaert RF, Herzenberg LA, Burakoff SJ, Crabtree G, Schreiber SL. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A 1990; 87: 9231–9235. 77 Francavilla A, Carr B, Starzl TE, Azzarone A, Carrieri G, Zeng QH. Effects of rapamycin (RPM) on cultured hepatocyte proliferation and gene expression. Hepatology 1992; 15: 871–877. 78 Grivell LA. Nucleo-mitochondrial interaction in yeast mitochondrial biogenesis. Eur J Biochem 1989; 182: 477–493. 79 Mohn K, Laz TM, Hsu J-C, Melby AE, Bravo R, Taub R. The immediate early-growth response in regenerating liver and insulin-stimulated H-35 cells; comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol Cell Biol 1991; 11: 381–390. 80 Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 1961; 3: 318–356. 81 Leffert HL, Koch KS. Proliferation of hepatocytes. In: Symposium on Hepatotrophic Factors. CIBA Foundation Symposium 1978; 55: 61–94. 82 Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990; 4: 176–187. 83 Francavilla A, Starzl TE, Van Thiel DH, Barone M, Polimeno L. Regeneration. In: AV Lebouton, ed. Molecular and cell biology of the liver. Boca Raton, FL: CRC Press, 1993: 309–346. 84 Fausto N. Hepatic regeneration. In: D Zakim, TD Boyer, eds. Hepatology: a textbook of liver disease. Philadelphia: W.B. Saunders Co., 1990: 49–64. 85 Sasaki Y, Zhang XF, Nishiyama M, Avruch J, Wands JR. Expression and phosphorylation of insulin receptor substrate 1 during rat liver regeneration. J Biol Chem 1993; 268: 3805–3808. 86 Stagsted J, Reaven GM, Hansen T, Goldstein A, Olsson L. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell 1990; 62: 297–307. 87 Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994; 14: 489–497. 88 McCormick F. How receptors turn Ras on. Nature 1993; 363: 15–16. 89 Rubartelli A, Bajetto A, Allavena G, Wollman E, Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 1992; 267: 24161–24164. 90 Flye MW, Yu S. Augmentation of cell-mediated cytotoxicity following 50% partial hepatectomy. Transplantation 1990; 49: 581–587. 91 Yoshimura S, Kamada N. Effect of cyclosporin A on liver regeneration following partial hepatectomy in the mouse. Transplant Proc 1989; 21: 911–912. 92 Sato Y, Tsukada K, Matsumoto Y, Abo T. Interferon-y inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liver. Hepatology 1993; 18: 340–346. Citing Literature Volume20, Issue3September 1994Pages 747-757 ReferencesRelatedInformation